Navigation Links
Mice Exposed to Smoke Helped by Blood Pressure Drug: Study
Date:1/6/2012

FRIDAY, Jan. 6 (HealthDay News) -- The blood pressure medicine losartan [Cozaar] helped prevent lung damage in mice that were exposed to cigarette smoke for two months, researchers say.

Specifically, the drug prevented lung tissue breakdown, airway wall thickening, inflammation and lung overexpansion in the animals, according to the Johns Hopkins researchers.

The findings have led to a clinical trial of losartan in people with smoking-related chronic obstructive pulmonary disease (COPD). About 12 million Americans have COPD, which is the third leading cause of death in the United States.

The study, published in the Jan. 3 issue of the Journal of Clinical Investigation, was funded by drugmaker Merck & Co. and the U.S. National Heart, Lung and Blood Institute.

"The results of our study in mice suggest that losartan or similar drugs could serve as an effective treatment for smoking-related lung diseases in humans," senior investigator Dr. Enid Neptune, a pulmonologist and assistant professor at the Johns Hopkins University School of Medicine, said in a Hopkins news release.

"And because these drugs are already approved for use in the United States as safe and effective treatments for hypertension, incorporating them into our treatment regimen for COPD would be quite rapid," Neptune added.

"It is very exciting that an existing medication has proven capable in an animal model of not only treating the problems of COPD, but also disrupting the biological pathway that precipitated them," pulmonologist Dr. Robert A. Wise, a Johns Hopkins professor who is leading the human clinical studies, said in the news release.

"If our tests in people prove successful, we could help restore lung health to millions of people who have suffered from tobacco addiction," Wise added.

Existing therapies for smoking-related COPD mainly provide relief of symptoms, such as shortness of breath, coughing and mucus production, Wise said. Blood pressure-lowering drugs may also help and some patients have surgery to remove damaged sections of the lung or undergo lung transplants.

While the findings of the new study are promising, scientists note that research involving animals often fails to produce similar results in humans.

More information

The American Academy of Family Physicians has more about chronic obstructive pulmonary disease.

-- Robert Preidt

SOURCE: Johns Hopkins Medicine, news release, Jan. 3, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. WTC workers exposed earlier to dust cloud have higher risk of atherosclerotic lesions
2. Parkinsons disease risk greater in those exposed to trichloroethylene
3. Women exposed to diethylstilbestrol in the womb face increased cancer risk
4. Health Woes Still Strike Women Exposed to Banned Pregnancy Drug
5. Preterm infants exposed to stressors in NICU display reduced brain size
6. World Trade Center-exposed NYC firefighters face increased cancer risk
7. 17 percent of cancer nurses unintentionally exposed to chemotherapy, U-M study finds
8. Women Exposed to Combat Trauma as Resilient as Men: Study
9. High risk of Parkinsons disease for people exposed to pesticides near workplace
10. Adalimumab levels detected in cord blood and infants exposed in utero
11. Pet Dogs May Be Exposed to High Levels of Flame Retardants
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mice Exposed to Smoke Helped by Blood Pressure Drug: Study
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology: